Exhaled endogenous particles contain lung proteins
A Bredberg, J Gobom, AC Almstrand… - Clinical …, 2012 - academic.oup.com
BACKGROUND We recently developed a novel, noninvasive method for sampling
nonvolatile material from the distal airways. The method is based on the collection of …
nonvolatile material from the distal airways. The method is based on the collection of …
Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status
E Fireman Klein, Y Adir, A Krencel, R Peri… - … Journal of Chronic …, 2019 - Taylor & Francis
Purpose Ultrafine particles (UFP) are toxic due to their small size and penetration into
deeper lung compartments. We aimed to evaluate the exhaled breath condensate (EBC) …
deeper lung compartments. We aimed to evaluate the exhaled breath condensate (EBC) …
Patients with asthma demonstrate airway inflammation after exposure to concentrated ambient particulate matter
NE Alexis, YCT Huang, AG Rappold… - American journal of …, 2014 - atsjournals.org
Of the three major particulate matter (PM) size fractions (ultrafine, fine, and coarse), coarse
PM (PM2. 5-10) has been the least examined in terms of its health effects on susceptible …
PM (PM2. 5-10) has been the least examined in terms of its health effects on susceptible …
[HTML][HTML] Surfactant protein A in particles in exhaled air and plasma
H Koca, A Farbrot, AC Olin, ÖI Emilsson - Respiratory Physiology & …, 2022 - Elsevier
Respiratory tract lining fluid (RTLF) is an important component of the lung epithelial barrier.
Pathological changes in RTLF may cause increased permeability of the epithelial barrier …
Pathological changes in RTLF may cause increased permeability of the epithelial barrier …
Use of asthmatic pulmonary function test data to predict lung deposition
RJ Robinson, RL Doolittle… - Journal of aerosol …, 2007 - liebertpub.com
Asthma is a complex disease that alters both breathing patterns and airway morphology.
Lack of experimental data or model simulations utilizing realistic in vivo breathing conditions …
Lack of experimental data or model simulations utilizing realistic in vivo breathing conditions …
Peripheral airspace dimensions in patients with COPD
T Beinert, P Brand, J Behr, C Vogelmeier, J Heyder - Chest, 1995 - Elsevier
Monodisperse aerosol particles can be used to assess noninvasively intrapulmonary
airspace dimensions. Since emphysematic changes in the peripheral lung are difficult to …
airspace dimensions. Since emphysematic changes in the peripheral lung are difficult to …
Targeting the small airways with dry powder adenosine: a challenging concept
E van der Wiel, AJ Lexmond… - European clinical …, 2017 - Taylor & Francis
Background: Small-particle inhaled corticosteroids (ICS) provide a higher small airway
deposition than large-particle ICS. However, we are still not able to identify asthma patients …
deposition than large-particle ICS. However, we are still not able to identify asthma patients …
[HTML][HTML] Exhaled breath particles as a novel tool to study lipid composition of epithelial lining fluid from the distal lung
P Larsson, O Holz, G Koster, A Postle, AC Olin… - BMC Pulmonary …, 2023 - Springer
Background Surfactant phospholipid (PL) composition plays an important role in lung
diseases. We compared the PL composition of non-invasively collected exhaled breath …
diseases. We compared the PL composition of non-invasively collected exhaled breath …
The small airways and distal lung compartment in asthma and COPD: a time for reappraisal
To cite this article: Contoli M, Bousquet J, Fabbri LM, Magnussen H, Rabe KF, Siafakas NM,
Hamid Q, Kraft M. The small airways and distal lung compartment in asthma and COPD: a …
Hamid Q, Kraft M. The small airways and distal lung compartment in asthma and COPD: a …
Improvement of simulated aerosol deposition efficiency in asthmatic subjects by altering particle inhalation time
Rationale: Optimization of regional particle dosimetry in asthmatic subjects may improve
tissue dose concentrations while reducing adverse side effects. Recently, we developed a …
tissue dose concentrations while reducing adverse side effects. Recently, we developed a …